|
Volumn 9, Issue 1, 2002, Pages 43-51
|
Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOOXYGENASE 2;
ENZYME INHIBITOR;
ISOENZYME;
ISOXAZOLE DERIVATIVE;
MEMBRANE PROTEIN;
MORPHINE;
NARCOTIC ANALGESIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE;
PTGS2 PROTEIN, HUMAN;
SULFONAMIDE;
VALDECOXIB;
AGED;
ANALYSIS OF VARIANCE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG ANTAGONISM;
DRUG COMBINATION;
FEMALE;
HIP ARTHROPLASTY;
HUMAN;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PAIN ASSESSMENT;
PATIENT CONTROLLED ANALGESIA;
POSTOPERATIVE PAIN;
RANDOMIZED CONTROLLED TRIAL;
TIME;
AGED;
ANALGESIA, PATIENT-CONTROLLED;
ANALGESICS, OPIOID;
ANALYSIS OF VARIANCE;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHROPLASTY, REPLACEMENT, HIP;
CYCLOOXYGENASE 2;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
ISOENZYMES;
ISOXAZOLES;
MALE;
MEMBRANE PROTEINS;
MIDDLE AGED;
MORPHINE;
PAIN MEASUREMENT;
PAIN, POSTOPERATIVE;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
SULFONAMIDES;
TIME FACTORS;
|
EID: 0036371187
PISSN: 10752765
EISSN: None
Source Type: Journal
DOI: 10.1097/00045391-200201000-00009 Document Type: Article |
Times cited : (144)
|
References (0)
|